| MYOPATHY, NEUROMUSCULAR JUNCTION & NERVE DISORDERS: Points in differential diagnosis | |||
|---|---|---|---|
| 1. Distinctive Features: Most myopathies have weakness that is maximal proximally. | |||
|
Extraocular muscles weak Myasthenia Gravis (MG) Thyroid; Botulism Mitochondrial: KS; PEO; MNGIE Centronuclear; Multicore Oculopharyngeal MD; IBM + Contracture Oculopharyngodistal myopathy Congenital ophthalmoplegias |
Periocular without EOM Weakness Dystrophies: Myotonic; FSH; Oculopharyngeal Myasthenia Gravis (MG) Congenital Myopathies Polymyositis |
Bulbar dysfunction MG; Thyroid; Cranial nerve Δ Oculopharyngeal MD Distal myopathy (MPD2) Polymyositis: IBM; Scleroderma Motor neuron Δ: ALS; BSMA Pseudobulbar; Fazio-Londe Brown-Vialetto-van Laere |
Common: MG; PM; ALS Focal myopathy: Neck; Paraspinous Rare: FSH dyst; LMN synd; IBM; Rod; PROMM; Acid maltase; ê K+ Carnitine; Endocrine; Desmin |
|
Dystrophy: Myotonic; FSH Scapuloperoneal Myopathy: Congenital; Distal Glygogenoses: Debrancher Phosphorylase b kinase Neuropathy + Myopathy: Paraneoplastic; Sarcoid; Mitochondria; HIV; Colchicine; Chloroquine) |
Acute weakness Myasthenia gravis; Myoglobinuria Myosin loss myopathy; Carnitine ê Periodic paralysis: X-Episodic Xp22 Hypo K+: CACNA1S; SCN4A; KCNE3 Hyper K+: SCN4A; KCNE3 Andersen: KCNJ2 Mg é; PO4 ê; Barium Rule out: Neuropathy; Spinal cord |
Cachexia: Wt loss > 15% Disuse; Steroid myopathy; Paraneoplastic; Aging |
Dystrophy: Scapuloperoneal; FSH Absent muscles; Shoulder joint Δ |
|
Weakness > Wasting Polymyositis; Myoglobinuria; Periodic Paralysis; Myasthenia gravis; Neuropathy + conduction block |
Quadriceps weak Myopathy: Becker; Ring fiber Myositis: IBM; Mitochon; Focal Nerve: Femoral; LS plexopathy; Diabetic amyotrophy; L3-L4 root |
||
|
Myoglobinuria Malignant Hyperthermia; Central core King-Denborough; DMD (Some) ê K+: Licorice; Li; Thiazide; Amphotericin; Laxative Infections; Mitochondrial; Trauma Muscle: Ischemia; Overactivity; PM Neuroleptic malignant syndrome Clofibrate + Renal failure; Cyclosporine A + Lovastatin Toxins: Venoms; IV drugs Oral: Haff; Mushrooms; EtOH |
Muscle activity Brody's syndrome: ATP2A1 Cramps: Benign Myoedema Dominant (Thomsen): CLCN1 (Cl-) Recessive (Becker): CLCN1 Acetazolamide responsive: SCNA4 Myotonic Dystrophy 1: DMPK, CTG rep Myotonic Dystrophy 2: ZNF9, CCTG rep Paramyotonia: Na+ channel (SCNA4) Periodic paralysis, Hyperkalemic Schwartz-Jampel: Perlecan Neural & Spinal activity |
Cardiac disorders Dystrophy: DMD/Becker; Myotonic; McLeod; Emery-Dreifuss; Barth; Scapuloperoneal; Desmin Polymyositis; Nemaline rod Carnitine ê; Desmin é Mitochondrial; Amyloid Drugs: Metronidazole; Emetine; Chloroquine; Clofibrate; Colchicine Cardiomyopathy + cores Periodic paralyses |
Respiratory Failure Myasthenia gravis Myosin-loss myopathy Acid Maltase Amyloid; Desmin Polymyositis (Jo-1) Congenital Myopathy: Rod; Centronuclear Hydroxychloroquine Neural: Phrenic lesions Arnold-Chiari; Churg-Strauss Brachial plexopathy; ALS GI disorders: See Neuropathy |
|
Muscle pain Myositis: + Connective tissue dis Polymyalgia; Rhabdomyolysis Infections: Trichinosis; Brucellosis Myoadenylate deaminase ê (< 2%) Myopathy +: Tubular aggregates; Focal ê mitochondria Drugs: Azathioprine; Steroid ê... Rule out: Small fiber neuropathy; Phlebitis Bone & joint pain; Muscle Ischemia |
Large muscles Neural Overactivity Partial denervation Endocrine: ê Thyroid; Acromegaly Hered: DMD; LGMD; Lipodyst; Myostatin Infection: Cysticercosis; Trichinosis; Schistosomiasis Storage: Glycogen; Amyloid Fat; Gangliosides Short stature: Schwartz-Jampel; Myhre |
Cramps Normal: Single Muscles Electrolyte: Dehydration Endocrine: Thyroid; ê Adrenal Drugs; Pregnant; Spine stenosis Cramp-fasciculation; Familial Myopathy: Becker Motor neuron: ALS Elecrically silent: phosphorylase Rippling muscle; Brody's |
Contractures Arthrogryposis Bethlem Myopathy Congenital MD Dermatomyositis Dystrophinopathies Emery-Dreifuss IM drug injections SMA: 5q; X-linked Tel Hashomer Williams-Beuren |
|
Congenital MD: Santavuori POMGnT1 1p32; Merosin 6q22; Fukuyama Fukutin; 9q31 Integrin-α7 12q13 Dystrophy: DMD; McLeod DM1; PROMM; HIBM 9p13 Thyroid; Mitochondrial Acid Maltase: Aneurysms Phosphoglycerate Kinase Myosin-loss Necrotizing Encephalopathy; Pipestem capillaries Hearing loss: FSH; Scapuloperoneal |
MG: Anti-AChR Binding & Modulating MG + Thymoma: Anti-striational LEMS: P-type Ca++ channel Polymyositis: t-RNA synthetase (Jo-1): Lung; Raynaud's; Arthritis Signal recognition Particle: Acute PM-Scl: PM + Scleroderma Decorin: M-protein; Myopathy |
Dystrophy X-linked: DMD/Becker Recessive: 2A-2I Dominant: 1C; Ankle contract Distal myopathy: Miyoshi Polymyositis Acid maltase Acute damage: Injection Rhabdomyolysis; Trauma Thyroid: Hypo- |
t-RNA synthetase (Jo-1 75%) Dermatomyositis: Child; Mi-2; Adult Microvasculopathies: DM; SRP Brachio-cervical inflammatory (BCIM) Granulomatous ± Sarcoid Idiopathic myositis: Poly-; Focal Inclusion body (IBM); PM-Mitochondrial Malignancy; Toxic Hereditary: FSH |
| 2. Myasthenic Syndromes | 3. Hereditary Myopathy Syndromes | |
|
Acquired MG: Immune ± Thyroid or Thymoma; Lambert-Eaton myasthenic syndrome (LEMS) Congenital & Familial: Presynaptic: Familial infantile (ChAT; 10q11) ê Synaptic vesicles & Quantal release Congenital Lambert-Eaton-like Episodic ataxia 2: CACNA1A; 19p13 Synaptic: AChE deficiency (ColQ; 3p25) Postsynaptic: AChR α β δ e; Rapsyn; Plectin AChRs: Kinetic Δ & ê # @ NMJs AChRs: Kinetic Δ & Normal # @ NMJs é Conductance & Fast closure of AChRs ê ACh-affinity & Fast-channel AChRs: ê #s @ NMJs & Kinetic WNL Rapsyn (11p11): ê AChRs @ NMJs Plectin 8q24; MuSK 9q31; Dok-7 4 Apnea & Bulbar: SCN4A 17q35 Other syndromes: Familial limb-girdle; Congenital LEMS-like; Familial immune |
Dominant: 1A Myotilin (TTID), 5q31; 1B LMNA, 1q11; 1C Cav-3, 3p25; 1D 7q; 1E 6q23; 1F 7q32; 1G 4p21; Cytoplasmic body 2q24 & 2q21; Emery-Dreifuss LMNA; DM1 DMPK CTG rpt, 19q13; DM2 ZNF9, 3q21 Bethlem COL6A, 21q22 & 2q37; FSH 4q35; IBM3 Myosin HC2, 17p13; ZASP, 10q22; Oculopharyngeal PABP2 GCG rpt, 14q11; Spheroid body Desmin 2q35; αB-crystallin 11q22; Paget VCP, 9p13 Dysplasia Diaphys TGFB1, 19q13; Epiphys COL9A3, 20q13 Recessive: 2A Calpain-3, 15q15; 2B Dysferlin, 2p12; Cav-3; Sarcoglycan 2C γ, 13q12; 2D α, 17q21; 2E β, 4q12; 2F δ, 5q33 2G Telethonin, 17q11; 2H TRIM32, 9q31; 2I FKRP, 19q13; 2J Titin, 2q31; 2K POMT1, 9q34; 2L, 11p13; 2M Fukutin, 9q31; CMD: Nl CNS FKRP, 19q13; Rigid spine SEPN1, 1p35 Respiratory failure 1q42; Ullrich COL6A; 21q22 & 2q37 X-linked: Barth Tafazzin, Xp28; Autophagy Xq28; Emery-Dreifuss Emerin, Xq28; McLeod XK, Xp21 Becker & Duchenne Dystrophin; Xq21; Danon LAMP-2; Xq24; Scapuloperoneal |
Distal Myopathies Dominant: Finnish Titin, 2q31: Late; Ant Tib Gowers-Laing (MPD1) MYH7, 14q11: Adult; Ant leg IBM1: Quad weakness MPD3: Adult, Asymmetric; LGD 1A & 1C IBM +: Paget's VCP, 9p13; Resp failure 6q27 Oculopharyngodistal; Scapuloperoneal 12q13 Vocal cord & Pharyngeal (MPD2) 5q31 Myofibrillar: Desmin; αB-crystallin; TTID; ZASP SEPN1; Filamin C; BAG3 Recessive: Nonaka & IBM2 GNE, 9p12: Quad sparing Miyoshi & LGD 2B Dysferlin, 2p12-14 Early adult; Posterior leg Other myopathies Barnes; Congenital; Lipid; Glycogen; Familial MG; Tubular Aggregates |